...
首页> 外文期刊>World Journal of Surgical Oncology >Comparison of robotic and laparoscopic rectal cancer surgery: a meta-analysis of randomized controlled trials
【24h】

Comparison of robotic and laparoscopic rectal cancer surgery: a meta-analysis of randomized controlled trials

机译:机器人和腹腔镜直肠癌手术的比较:随机对照试验的荟萃分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Robotic and laparoscopic surgery for rectal cancer has been applied in the clinic for decades; nevertheless, which surgical approach has a lower rate of postoperative complications is still inconclusive. Therefore, the aim of this meta-analysis was to compare the postoperative complications within 30?days between robotic and laparoscopic rectal cancer surgery based on randomized controlled trials. Randomized controlled trials (until May 2020) that compared robotic and laparoscopic rectal cancer surgery were searched through PubMed, EMBASE, the Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, and China Biology Medicine disc (CBMdisc). Data regarding sample size, clinical and demographic characteristics, and postoperative complications within 30?days, including overall postoperative complications, severe postoperative complications (Clavien-Dindo score ≥ III), anastomotic leakage, surgical site infection, bleeding, ileus, urinary complications, respiratory complications, conversion to open surgery, unscheduled reoperation, perioperative mortality, and pathological outcomes, were extracted. The results were analyzed using RevMan v5.3. Seven randomized controlled trials that included 507 robotic and 516 laparoscopic rectal cancer surgery cases were included. Meta-analysis showed that the overall postoperative complications within 30?days [Z = 1.1, OR = 1.18, 95% CI (0.88–1.57), P = 0.27], severe postoperative complications [Z = 0.22, OR = 1.12, 95% CI (0.41–3.07), P = 0.83], anastomotic leakage [Z = 0.96, OR = 1.27, 95% CI (0.78–2.08), P = 0.34], surgical site infection [Z = 0.18, OR = 1.05, 95% CI (0.61–1.79), P = 0.86], bleeding [Z = 0.19, OR = 0.89, 95% CI (0.27–2.97), P = 0.85], ileus [Z = 1.47, OR = 0.66, 95% CI (0.38–1.15), P = 0.14], urinary complications [Z = 0.66, OR = 1.22, 95% CI (0.67–2.22), P = 0.51], respiratory complications [Z = 0.84, OR = 0.64, 95% CI (0.22–1.82), P = 0.40], conversion to open surgery [Z = 1.73, OR = 0.61, 95% CI (0.35–1.07), P = 0.08], unscheduled reoperation [Z = 0.14, OR = 0.91, 95% CI (0.26–3.20), P = 0.89], perioperative mortality [Z = 0.28, OR = 0.79, 95% CI (0.15–4.12), P = 0.78], and pathological outcomes were similar between robotic and laparoscopic rectal surgery. Robotic surgery for rectal cancer was comparable to laparoscopic surgery with respect to postoperative complications within 30?days.
机译:对直肠癌的机器人和腹腔镜手术已经在诊所应用了几十年;然而,哪种外科手术方法较低的术后并发症仍然不确定。因此,该荟萃分析的目的是将术后并发症与基于随机对照试验的机器人和腹腔镜直肠直肠癌手术之间的术后并发症进行比较。随机对照试验(直到5月2020年)通过PubMed,Embase,Cochrane图书馆,中国国家知识基础设施(CNKI),万方数据知识服务平台和中国生物医学盘(CBMDISC)进行了比较了机器人和腹腔镜直肠癌手术。关于样本大小,临床和人口统计学特征的数据,30?天内的术后并发症,包括整体术后并发症,严重的术后并发症(Clavien-dindo评分≥III),吻合泄漏,手术部位感染,出血,肠梗阻,尿复杂性,呼吸提取并发症,转化为开放手术,未划分的重新进食,围手术期死亡率和病理结果。使用Revman V5.3分析结果。包括七项随机对照试验,包括507个机器人和516腹腔镜直肠癌手术病例。荟萃分析表明,30?天[Z = 1.1,或= 1.18,95%CI(0.88-1.57),p = 0.27],P = 0.27]内的整体术后并发症,严重的术后并发症[Z = 0.22,或= 1.12,95% CI(0.41-3.07),P = 0.83],吻合漏液[Z = 0.96,或= 1.27,95%CI(0.78-2.08),P = 0.34],手术部位感染[Z = 0.18,或= 1.05,95 %CI(0.61-1.79),P = 0.86],出血[Z = 0.19,或= 0.89,95%CI(0.27-2.97),P = 0.85],inleus [Z = 1.47,或= 0.66,95%CI (0.38-1.15),p = 0.14],尿络合物[Z = 0.66,或= 1.22,95%CI(0.67-2.22),P = 0.51],呼吸并发症[Z = 0.84,或= 0.64,95%CI (0.22-1.82),P = 0.40],转化为开放手术[Z = 1.73,OR = 0.61,95%CI(0.35-1.07),P = 0.08],未安排的重新组合[Z = 0.14,或= 0.91,95 %CI(0.26-3.20),P = 0.89],围手术期死亡率[Z = 0.28,或= 0.79,95%CI(0.15-4.12),P = 0.78]和病理结果在机器人和腹腔镜直肠手术之间相似。直肠癌的机器人手术与腹腔镜手术相比,在30?天内的术后并发症相比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号